Service description and background. 1.1. Patients and the general public access community pharmacies for self-care advice and to purchase over the counter medicines. It is however difficult sometimes for patients to know when it might be more appropriate to access GP advice. It is estimated that 6% of all GP consultations could be safely transferred to a community xxxxxxxx0 (20.4 million appointments per year) and there is good evidence that the advice provided by community pharmacists as part of a consultation about symptoms of minor illness will result in the same outcome as if the patient went to see their GP or attended an Emergency Department.3
Service description and background. This service is commissioned as a local enhanced service under the powers given to NHS England by The Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013 paragraph 14 (1) (h) and (o). Community Pharmacists will contribute to the reduction of prescribed unwanted medicines, which currently are wasted. This service will be undertaken at the point of dispensing. This will help to prevent patient’s stockpiling of prescribed medicines and reduce inefficiencies in prescribing on FP10s. The service will inform GP repeat prescribing processes thus contributing to improved patient outcomes through harm reduction, reduced hospital admissions, and increased medicine concordance. It is expected that the service will encourage Pharmacists to carry out Medicine Use Reviews (MUR) with patients who they have identified as having issues with their prescribed medicines or processes around ordering repeat medicines. The object of this scheme is to reduce the burden of waste medicines, which has far reaching implications both financially and in terms of harm and health outcomes for patients: To reduce the number of unwanted medicines dispensed and therefore wasted, by not dispensing items not required by the patient. To notify the prescriber when an item prescribed has not been dispensed. To promote, support and encourage good repeat / prescribing practices with patients and GP practices. To highlight under usage of medicines to the prescriber. To inform the prescriber whether the continued supply or non-supply of items would be considered clinically significant. To highlight prescribing inefficiencies to the prescriber. To reduce unnecessary prescribing costs.
Service description and background. This service is commissioned as a local enhanced service under the powers given to NHS England by The Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013 paragraph 14 (1) (j). This service is available to all patients who are exempt from paying prescription charges. The patients must be registered with a GP practice located within the Clinical Commissioning Group. Patients are at liberty to refuse this service. Patients can receive advice and/or treatment under the Minor Ailments Scheme on the conditions listed in Appendix 6. Patients who pay for their prescriptions should be referred to a pharmacy for advice and to purchase over the counter medicines in the usual way. This service is a "stepping stone" towards the "Self-Care" approach to healthcare. Only Community Pharmacies who are committed to making staff available to provide the service and who have completed the necessary training for the conditions listed in Appendix 6 will be included in the Minor Ailments Scheme.
Service description and background. This service is commissioned as a local enhanced service under the powers given to NHS England by The Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013 paragraph 14 (1) (i). Community pharmacies can support patients staying in their own homes rather than other care settings by supporting care agencies in the safe administration of medicines and the appropriate recording of the same.
Service description and background. This service is commissioned as a local enhanced service under the powers given to NHS England by The Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013 paragraph 14 (1) (i). An ‘authorised person’ in this service specification is a person acting under arrangements with the CCG for the purpose of coordinating access to this service. The pharmacy will help support vulnerable people, who require more support than a ‘one off’ adjustment, as covered under the Disability Discrimination Xxx 0000 criteria. The pharmacy will be contacted by an authorised person for professional discussions about the appropriate level or kind of support, if any, required by the person to help them take their medicines as intended. If support is necessary, the authorised person and Pharmacy will agree with the person the appropriate level or kind of support. The pharmacy may provide advice, support and assistance to the person, family member or informal carer with a view to improving the patient’s knowledge and use of their drugs and their compliance, or may need to refer to their GP for further referral to other health and social care professionals where appropriate. The pharmacy will provide the support as described within the Open A ction Plan contained within the Patient file set up by the authorised person.
Service description and background. This service is commissioned as a local enhanced service under the powers given to NHS England by The Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013 paragraph 14 (1) (u). In an emergency, a pharmacist can supply prescription only medicines (POMs) to a patient (who has previously been prescribed the requested POM) without a prescription at the request of a patient. This emergency supply is not an NHS service and patients may therefore be asked to pay the cost of the medicine. This can lead to some patients seeking supplies or emergency prescriptions from urgent or emergency care providers or placing extra demand on GP appointments. When demand is high it may not be practical to obtain a prescription in a timely way to meet immediate need. The Community Pharmacy Emergency Supply Service allows the emergency supply of a patient’s medicine at NHS expense in order to reduce the number of patients contacting urgent and emergency care providers. This may include both prescription only and other medicines usually obtained on prescription by the patient from their GP. The emergency supply provisions permit the supply of sufficient quantities of most prescription only medicines for up to 30 days treatment, this service specification allows for up to 7 days treatment only. Exceptions apply for inhalers and creams / ointments, where a manufacturer’s pack can be supplied. Schedule 1, 2 or 3 controlled drugs (except phenobarbitone or phenobarbitone sodium for epilepsy) cannot be supplied in an emergency. Quantities of other medicines should be in line with this. During a pandemic situation, a pharmacist may make an emergency supply against a request by a patient’s representative; at all other times the request must be made directly by the patient. The purpose of the Community Pharmacy Emergency Supply Service is to ensure that patients can access an urgent supply of their regular prescription medicines where they are unable to obtain a prescription before they need to take their next dose. The service may be needed because the patient has run out of a medicine, or because they have lost or damaged their medicines, or because they have left home without them. The aim of this service is to relieve pressure on urgent and emergency care services and general practitioner appointments at times of high demand. In an emergency, a pharmacist can supply prescription only medicines (POMs) to a patient (who has previously been prescribed the requ...
Service description and background. 1.1. This pilot will specifically evaluate the implementation by community pharmacy of direct referrals to secondary care diagnostics/Rapid Diagnostic Service (RDS) triage teams for people with suspected cancer signs and symptoms. The pilot will initially focus on testing safety and technical feasibility with a small number of Community Pharmacies before expanding to full pilot roll out and data collection to evaluate the benefits of direct referrals from Community Pharmacy for people presenting with suspected cancer symptoms.
Service description and background. 2.1 The Community Pharmacy Vaccination Service is a further phase of the Vaccine Transformation Programme (VTP) in developing and evaluating alternative options prior to April 2022, when flu vaccination may no longer be part of the General Medical Services (GMS)
Service description and background. The Marketing Spend Management Applications provide Marketers the visibility and process support to enable spending of marketing budgets. These Applications are in the process of being transitioned to a new platform to improve the efficiency and effectiveness of the Brand Marketers. During the transition the Supplier and Buyer organizations will need to continue to provide application and business process support for the legacy Applications. In addition, the Buyer and Supplier organizations will need to deliver the configuration, development, testing, change management and training of the new [ * * * ] application and all interfaces to SAP.
Service description and background. 2.1 For most healthy people, influenza (flu) is an unpleasant but usually self-limiting disease. However, older people, pregnant women and those with an underlying medical condition are at particular risk of becoming more adversely affected should they succumb to the illness. 2.2 Flu is a key factor in NHS resilience. It impacts on those who become ill, the resultant NHS services that provide direct care as a consequence, and on the wider health and social care system. The annual immunisation programme helps to reduce unplanned hospital admissions and pressure on the Emergency Departments. It is therefore a critical element of a system-wide approach in maintaining the resilience of the healthcare services during the critical winter period. 2.3 This NHS Borders Community Pharmacy Seasonal Influenza Vaccination Service is part of the alternative options for vaccination in NHS Borders 2.4 This service will be offered by Community Pharmacies who wish to participate as per PCA(P)(2020)17 allowing accredited personnel to administer influenza vaccine to eligible patients in the agreed cohorts as a free NHS service. 2.5 The pharmacy phase of the Community Pharmacy Seasonal Flu Immunisation Service will run from around 1st October 2020 to 31st March 2021 complementing the GP practice and other NHS facilities which also commence around 1st October 2020. 2.6 The vaccination is to be administered to eligible patients meeting the criteria specified in the NHS Borders PGD and who do not have any valid contraindications to vaccination. The PGD is available on the Community Pharmacy website at: xxxx://xxx.xxxxxxxxxx.xxxx.nhs.uk/media/750752/PH26-2020-08-20-inactivated-flu-vaccine-v1-1-2020-21-season.pdf
